Shopping Cart

Bob Proulx Discusses Imagion's Recent Progress with Boardroom Media

Bob Proulx Discusses Imagion's Recent Progress with Boardroom Media

Funds raised in Imagion’s recent Rights Issue will be used to fund the first-in-human trials for the Company’s MagSense technology. Listen to CEO Bob Proulx further discuss Imagion’s progress in this recent interview with Boardroom Media.

Related Articles

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.